Novo Nordisk ties up with Metaphore to develop new obesity drugs
Novo Nordisk signed a research tie-up with U.S. biotech firm Metaphore on Thursday to develop next-generation obesity drugs.
Novo Nordisk signed a research tie-up with U.S. biotech firm Metaphore on Thursday to develop next-generation obesity drugs.
Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors on Novavax’s board, after the COVID-19 vaccine…
AstraZeneca plans to build a $1.5 billion manufacturing facility in Singapore to produce a promising category of cancer-killing drugs called antibody-drug conjugates (ADCs), the Anglo-Swedish…
In this enlightening episode of Dr. Olli Tikkanen’s podcast, we are joined by the esteemed Professor James F. Sallis, a newly appointed Distinguished Professor in…
South Africa remains at risk of bird flu due to delays in the roll-out of a broad vaccination programme, the country’s largest chicken producer, Astral…
Certain genes may identify patients with obesity who are most likely to respond strongly to Novo Nordisk’s weight-loss drug Wegovy, researchers reported on Monday.
AstraZeneca is planning to build a $1.5 billion manufacturing facility in Singapore in an effort to enhance its antibody drug conjugates (ADCs) portfolio, the drugmaker…
Certain genes may identify patients with obesity who are most likely to respond strongly to Novo Nordisk’s weight-loss drug Wegovy, researchers reported on Monday.
Arkansas and Oklahoma had highest HCQ, ivermectin prescription rates
Sam Chang converses with Neal Shore about the KEYNOTE-676 trial, focusing on combining pembrolizumab with BCG for high-risk NMIBC patients previously treated with BCG. This…
Ruchika Talwar interviews Amanda Myers about her study on at-home intravesical therapy for bladder cancer patients. Dr. Myers’ was inspired by patients’ desire for a…